When a deadly listeria outbreak swept across Canada in 2024, the initial headlines focused on recalls and rising case counts.
Natera delivers robust revenue growth, raising 2026 guidance to $2.74–$2.82 billion, but remains unprofitable. Read more on NTRA stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results